Acalabrutinib treatment for older (aged ≥80 years) and/or frail patients with CLL: primary end point analysis of the CLL-Frail trial
阿卡替尼治疗老年(≥80岁)和/或体弱的慢性淋巴细胞白血病患者:CLL-Frail试验的主要终点分析
期刊:Blood
影响因子:23.1
doi:10.1182/blood.2025028550
Simon, Florian; Ligtvoet, Rudy; Bohn, Jan-Paul; Nösslinger, Thomas; von Tresckow, Julia; Liersch, Rüdiger; Gaska, Tobias; Jentsch-Ullrich, Kathleen; Gärtner, Michael; Wolff, Thomas; Schwaner, Ingo; Wolf, Dominik; Schneider, Christof; Vehling-Kaiser, Ursula; Ritgen, Matthias; Spoer, Christian; Eckart, Michael; Decker, Thomas; Chakupurakal, Geothy; Schöttker, Björn; Kisro, Jens; Kreuzer, Karl-Anton; Tausch, Eugen; Stilgenbauer, Stephan; Robrecht, Sandra; Stumpf, Janina; Fink, Anna-Maria; Fürstenau, Moritz; Fischer, Kirsten; Goede, Valentin; Hallek, Michael; Eichhorst, Barbara